Moderna Sees Positive Results in Booster Shot

The vaccine maker Moderna announced ground breaking news about its new booster shot to fight against COVID-19.  

A third shot that will be administered six to eight months after the first dose is more effective against the new strains of the virus that have been popping up in Brazil and South Africa. The third dose of the Moderna vaccine showed that it was more effective and created higher levels of protective antibodies against the newer strains. 

In a statement, Moderna CEO Stephane Bancel said, “We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective against these newly detected variants.” 

She also mentioned that they are working on a new single dose shot, but that it is still in trial. “We look forward to sharing data on our multivalent booster candidate, mRNA-1273.211, which combines mRNA-1273 and mRNA-1273.351 in a single vaccine, when available. We will continue to make as many updates to our COVID-19 vaccine as necessary to control the pandemic.”

They are optimistic to have results more quickly than it took to create the two shot vaccine. 

Pfizer-BioNTech is also looking into a booster shot that will protect against the other variants. 

Hampden Keil

Hampden Keil is a senior at the University of Illinois majoring in journalism with a concentration in recreational sport and tourism. He loves everything to do with food and sports, especially hockey and football. He is an active member of Acacia Fraternity. Keil loves watching the Blackhawks and Bears. In the past, he served as an analyst for the Illini club hockey games.